Monash Ivf Group
- Short interest
- 1.31%
- −0.18 pp 30d
- as of 8 Oct 2026
- Reported shorts
- 5.1M
- Shares on issue
- 389.635M
Monash Ivf Group (MVF) Short Interest
Monash Ivf Group (ASX:MVF) had 1.31% of shares reported as short positions as of 8 Oct 2026, representing 5,113,681 shares. Monash Ivf Group operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Monash Ivf Group
Monash IVF Group is a provider of assisted reproductive services (ART) and ultrasound services. The company focuses on developing assisted reproductive technologies and tertiary level prenatal diagnostics. They operate clinics and provide related services to patients seeking fertility treatments.
Company profile →Monash Ivf Group (ASX:MVF) has 1.31% of its shares on issue reported as short positions as of 8 Oct 2026, or about 5,113,681 shares. Over the past 30 days that figure has fallen 0.18 percentage points, and over 90 days it has fallen 0.35 percentage points. Its highest recorded short interest was 7.53% in September 2025. MVF is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads MVF today
- Zanger BreakoutWatchScore 21rank 1168 of 1942
- CAN SLIMNot a candidate
- Minervini Trend TemplateWatchScore 37rank 439 of 1716
- Crowded-Short BreakoutWatchScore 24rank 204 of 1502
- Quality compoundersWatchScore 26rank 501 of 1669
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
MVF fundamentals
In the year to 30 Jun 2026, Monash Ivf Group (ASX:MVF) recorded revenue of A$269.5M and net profit after tax of A$7.4M. A year earlier it recorded revenue of A$271.9M and net profit after tax of A$25.0M. Year-on-year growth: revenue −0.9% (FY), EPS −70.3% (TTM). Net margin 2.8% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit), as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest MVF news
All news- Appointment of CFO
asx · 8 Oct 2026
- Important Dates for Shareholders
asx · 23 Sept 2026
- Monash IVF Group (ASX: MVF): Can Clinical and Commercial Progress Drive Its Next Growth Chapter? - Kalkine
googlenews · 7 Sept 2026
Company details
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss MVF
Start a research thread or post the first pulse update